According to its 10-Q quarterly filing, C.R. Bard finally paid $3.6 million in damages in the first Avaulta transvaginal mesh (TVM) case, originally filed in July 2012.
Although C.R. Bard ceased selling Avaulta in July of 2012, the company still faces over 21,000 product liability lawsuits regarding its transvaginal mesh products. MT Services LLC, a Lawsuit Settlement News Reporting Company updates us about the first TVM pelvic mesh case to go to trial. This was also the first transvaginal mesh case in which a plaintiff was awarded damages rather than the case resulting in a settlement.
Originally, the jury had reached a verdict awarding $5.5 million to the plaintiff, however, the doctor who implanted the mesh was found to be at fault (40%), thus reducing Bard’s share of the damages to $3.6 million. C.R. Bard appealed, however, they were denied in February of this year.
According to an article on Mesh Medical Device News Desk, 12,735 of the aforementioned 21,000 cases were consolidated and are currently filed in the multidistrict litigation in a federal court in Charleston, West Virginia.
There have been six multidistrict litigations against different mesh manufacturers, consolidating more than 80,000 lawsuits against the companies. The lawsuits against the different manufacturers allege that the transvaginal mesh devices and bladder slings caused serious injuries, and the manufacturers involved have had verdicts against them, and have also agreed to high settlements.
Source: PR Newswire